tm
Seeing Is Believing
tm
Seeing Is Believing
VTGN is currently covered by 2 analysts with an average price target of $12.91. This is a potential upside of $10.09 (357.8%) from yesterday's end of day stock price of $2.82.
VistaGen Therapeutics's activity chart (see below) currently has 2 price targets and 12 ratings on display. The stock rating distribution of VTGN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 209 days.
Highest price target for VTGN is $13, Lowest price target is $5, average price target is $22.5.
Most recent stock forecast was given by ANDREW TSAI from JEFFERIES on 07-Dec-2023.
Currently out of the existing stock ratings of VTGN, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$12.3 (455.56%)
$6
1 years 3 months 11 days ago
(07-Dec-2023)
1/3 (33.33%)
$10.13 (208.01%)
27
Buy
$30
$27.3 (1011.11%)
$30
1 years 6 months 13 days ago
(05-Sep-2023)
0/2 (0%)
$23.79 (383.09%)
Hold
$9
2 years 7 months 24 days ago
(22-Jul-2022)
1/1 (100%)
$6.42 (248.84%)
809
What is VTGN (VistaGen Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VTGN (VistaGen Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VTGN (VistaGen Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VTGN (VistaGen Therapeutics)?
Which analyst is the currently most bullish on VTGN (VistaGen Therapeutics)?
Which analyst is the currently most reserved on VTGN (VistaGen Therapeutics)?
